Brainsway’s Deep TMS Treatment Approved By EU

Israeli company Brainsway Ltd., which develops non-invasive treatments using transcranial magnetic stimulation (TMS), has received the EU’s CE Marketing stamp of approval for its Deep TMS system. The company will use the system for treating autism, Alzheimer’s and cigarette addiction.

The approval was granted by MedCert, which is qualified for approving medical treatments by CE Marketing. Earlier this year, Brainsway won FDA and Health Canada approval.